Blueprint Medicines Corp (BPMC) — Cash Flow Reinvestment Rate
Blueprint Medicines Corp (BPMC) has a Cash Flow Reinvestment Rate of 0.69x as of September 2020, reinvesting $430.14 Million (capex $6.00K plus investments $-430.13 Million) from operating cash flow of $622.33 Million. Check BPMC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Blueprint Medicines Corp Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Blueprint Medicines Corp across 1 annual periods. Explore Blueprint Medicines Corp (BPMC) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Blueprint Medicines Corp (2020–2020)
Year-by-year capital reinvestment analysis for Blueprint Medicines Corp. For live market cap and broader valuation context, see how much is Blueprint Medicines Corp worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.12x | $434.25 Million | $387.04 Million | $3.16 Million | — |